91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Kirsten Sherman Cervati contributes to this media article which discusses the considerations for returning results to paediatric participants.
-
Advances in wearables, telemedicine and remote monitoring technology along with the convenience of in-home visits were bound to make decentralised and hybrid clinical trials standard with enough time. However, the COVID-19 pandemic accelerated their adoption and now, even with the hope that the pandemic will soon be behind us, hybrid and decentralised models are poised to become viable solutions in clinical trial design because of their inherent agility, inclusivity and most importantly, patient centricity.
-
Emily Mitchell, Executive Director, Decentralised Clinical Trials Operations and Christina Dinger, Director, Decentralised Clinical Trials Operations, run through .
This article was taken from Pharmafocus December 2021, pages 16-17. Samedan Ltd.
-
Shelley McLendon, Vice President, Vaccines and Infectious Disease, discusses .
-
discusses the substantial number of significant acquisitions and mergers in the pharma and life sciences industry, and features 91黑料’s $12bn acquisition of PRA Health Sciences back in February.
-
, recognising the significant contribution our French colleagues have made to our business in France and globally.
-
by Dr. Peter Schueler explores how digital and liquid biomarkers are developing, and how they can impact the future of neurological studies.
-
reporting on 91黑料's recent announcement that its Accellacare Site Network has entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities.
-
This article highlights .
-
Mitsu Rana, Senior Director of Project Management, shares her perspective on .
